Smile In
COVID-19
PREMs
quality of care
radiotherapy
technology assessment
Journal
Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525
Informations de publication
Date de publication:
13 Aug 2022
13 Aug 2022
Historique:
received:
09
07
2022
revised:
09
08
2022
accepted:
11
08
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
We report a mono-institutional experience regarding patient-perceived quality regarding the Chieti Radiotherapy Department, through RAMSI (Radiotherapy Amica Mia-SmileIN Patient-reported experience measures (PREMs) were assessed as follows: Patient-centric welcome perception (PCWP), Comfort, Professional skills and Punctuality. Patients could give anonymous feedback using HappyOrNot technology through four totems located in strategic areas within the center. An internal benchmark was obtained using the feedback received after a preliminary observation period. The SI Experience Index was collected, analyzed and compared. Weekly and monthly reports were generated. From February 2019 to February 2022, 8924 patients accessed the department; 17,464 daily treatments were recorded and 5830 points of feedback were collected: 896, 1267, 1125 and 2542 for PCWP, Comfort, Professional skills and Punctuality, respectively. A LINAC decommissioning period was analyzed, with decreases in the SI-Index score and Smile-IN approved percentage and an improvement after this period. Additionally, the COVID-19 pandemic was analyzed with a mild evaluations decrease for PREM's Welcome, Comfort and Punctuality (Δ-value: -9%, -3% and -4%, respectively), while Professional skills were always optimal. The RAMSI project was effective for assessing treatment quality perception, allowing for improving clinical procedures with corrective actions. The RAMSI project is ongoing.
Sections du résumé
BACKGROUND
BACKGROUND
We report a mono-institutional experience regarding patient-perceived quality regarding the Chieti Radiotherapy Department, through RAMSI (Radiotherapy Amica Mia-SmileIN
MATERIAL AND METHODS
METHODS
Patient-reported experience measures (PREMs) were assessed as follows: Patient-centric welcome perception (PCWP), Comfort, Professional skills and Punctuality. Patients could give anonymous feedback using HappyOrNot technology through four totems located in strategic areas within the center. An internal benchmark was obtained using the feedback received after a preliminary observation period. The SI Experience Index was collected, analyzed and compared. Weekly and monthly reports were generated.
RESULTS
RESULTS
From February 2019 to February 2022, 8924 patients accessed the department; 17,464 daily treatments were recorded and 5830 points of feedback were collected: 896, 1267, 1125 and 2542 for PCWP, Comfort, Professional skills and Punctuality, respectively. A LINAC decommissioning period was analyzed, with decreases in the SI-Index score and Smile-IN approved percentage and an improvement after this period. Additionally, the COVID-19 pandemic was analyzed with a mild evaluations decrease for PREM's Welcome, Comfort and Punctuality (Δ-value: -9%, -3% and -4%, respectively), while Professional skills were always optimal.
CONCLUSION
CONCLUSIONS
The RAMSI project was effective for assessing treatment quality perception, allowing for improving clinical procedures with corrective actions. The RAMSI project is ongoing.
Identifiants
pubmed: 36011190
pii: healthcare10081533
doi: 10.3390/healthcare10081533
pmc: PMC9408583
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
BMJ Open Qual. 2018 May 7;7(2):e000034
pubmed: 29756069
Healthcare (Basel). 2021 Sep 26;9(10):
pubmed: 34682948
Adv Radiat Oncol. 2020 Oct 29;5(Suppl 1):3-6
pubmed: 33145459
Oncol Lett. 2018 Feb;15(2):1823-1828
pubmed: 29434879
Lancet Oncol. 2015 Sep;16(10):1153-86
pubmed: 26419354
Infect Chemother. 2020 Dec;52(4):496-502
pubmed: 33263246
Cancer Diagn Progn. 2021 Jul 3;1(3):143-149
pubmed: 35399320
Asian Pac J Cancer Prev. 2021 Jan 01;22(1):19-24
pubmed: 33507674
J Cancer Educ. 2021 Jan 11;:
pubmed: 33432468
Int J Qual Health Care. 2017 Jun 01;29(3):314-326
pubmed: 28339923
Radiat Oncol. 2020 Sep 29;15(1):226
pubmed: 32993690
Int J Radiat Oncol Biol Phys. 2020 Jul 1;107(3):597-599
pubmed: 32199941
Radiother Oncol. 2020 May;146:223-229
pubmed: 32342863
Clin Oncol (R Coll Radiol). 2020 Jul;32(7):e160-e161
pubmed: 32354669
Radiol Med. 2020 Feb;125(2):214-219
pubmed: 31605353
Design Health (Abingdon). 2018 Feb 15;2(1):5-19
pubmed: 30009280
Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):618-627
pubmed: 32302681
In Vivo. 2021 May-Jun;35(3):1821-1828
pubmed: 33910868
Int J Radiat Oncol Biol Phys. 2020 Jul 1;107(3):600-601
pubmed: 32199942
Eur J Cancer. 2005 Sep;41(14):2120-31
pubmed: 16182120
Anticancer Res. 2014 May;34(5):2525-31
pubmed: 24778070
ESMO Open. 2020 Apr;5(2):
pubmed: 32295769
Asia Pac J Oncol Nurs. 2017 Jan-Mar;4(1):69-76
pubmed: 28217733